IRIS
MAGHNIE, MOHAMAD
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 28.464
AS - Asia 3.508
NA - Nord America 2.707
SA - Sud America 265
AF - Africa 62
OC - Oceania 4
Totale 35.010
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 27.963
US - Stati Uniti d'America 2.527
SG - Singapore 1.404
CN - Cina 888
VN - Vietnam 503
BD - Bangladesh 365
FR - Francia 235
BR - Brasile 144
HK - Hong Kong 122
CA - Canada 76
FI - Finlandia 61
DE - Germania 44
AR - Argentina 43
JP - Giappone 41
NL - Olanda 34
MX - Messico 33
CH - Svizzera 26
GB - Regno Unito 26
ID - Indonesia 25
EC - Ecuador 23
IN - India 23
CO - Colombia 21
IQ - Iraq 16
PK - Pakistan 16
RU - Federazione Russa 14
JM - Giamaica 13
VE - Venezuela 13
PH - Filippine 11
TR - Turchia 11
CR - Costa Rica 10
EG - Egitto 10
MA - Marocco 9
NI - Nicaragua 9
TH - Thailandia 9
CL - Cile 8
ES - Italia 8
JO - Giordania 8
MY - Malesia 8
UA - Ucraina 8
ZA - Sudafrica 8
KR - Corea 7
IE - Irlanda 6
IL - Israele 6
OM - Oman 6
PR - Porto Rico 6
RO - Romania 6
SV - El Salvador 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
DZ - Algeria 5
PL - Polonia 5
SN - Senegal 5
AU - Australia 4
GT - Guatemala 4
HN - Honduras 4
IR - Iran 4
KE - Kenya 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
RS - Serbia 4
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
DK - Danimarca 3
LT - Lituania 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BS - Bahamas 2
CG - Congo 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GP - Guadalupe 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MQ - Martinica 2
NG - Nigeria 2
PS - Palestinian Territory 2
QA - Qatar 2
SA - Arabia Saudita 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CM - Camerun 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
Totale 34.998
Salva come PNG Salva come JPEG
Città #
Genova 15.559
Genoa 7.704
Rapallo 2.260
Vado Ligure 1.962
Singapore 686
San Jose 645
Ashburn 364
Lauterbourg 217
Beijing 163
Ho Chi Minh City 156
New York 136
Hong Kong 118
Hanoi 112
Council Bluffs 86
Helsinki 59
Bordighera 58
Los Angeles 57
Milan 56
Santa Clara 52
Rome 39
Buffalo 34
Chicago 34
Tokyo 34
Boardman 31
Frankfurt am Main 31
Dallas 28
Zurich 25
Da Nang 23
Tianjin 22
Naples 21
Turin 21
Mexico City 20
Haiphong 18
Montreal 18
Phoenix 16
Orem 15
Philadelphia 15
Amsterdam 13
Atlanta 13
São Paulo 13
Toronto 13
Washington 13
Bologna 12
Houston 12
Newark 12
San Francisco 12
Can Tho 11
Piscataway 11
Des Moines 10
Managua 9
Quito 9
Baghdad 8
Brooklyn 8
Miami 8
San José 8
The Bronx 8
Bari 7
Cardiff 7
Detroit 7
Guayaquil 7
Hải Dương 7
Istanbul 7
Jacksonville 7
Secaucus 7
Shanghai 7
Alexandria 6
Belo Horizonte 6
Biên Hòa 6
Boston 6
Brescia 6
Cairo 6
Caracas 6
Charlotte 6
Cleveland 6
Columbus 6
Florence 6
Guangzhou 6
Kingston 6
Kuala Lumpur 6
Las Vegas 6
Medellín 6
Palermo 6
Augusta 5
Bangkok 5
City of London 5
Dakar 5
Dublin 5
Jersey City 5
Joinville 5
London 5
Modena 5
Ninh Bình 5
North Bergen 5
Padua 5
Rio de Janeiro 5
Sacramento 5
San Antonio 5
Thái Nguyên 5
Warren 5
Warsaw 5
Totale 31.353
Salva come PNG Salva come JPEG
Nome #
Blood Cell Mitochondrial DNA Content and Premature Ovarian Aging. 594
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. 319
Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies 297
Age- and sex-matched reference curves for serum collagen type I C-telopeptides and bone alkaline phosphatase in children and adolescents: An alternative multivariate statistical analysis approach 241
A longitudinal printo study on growth and puberty in juvenile systemic lupus erythematosus. 238
Characteristics of a nationwide cohort of patients presenting with Isolated Hypogonadotropic Hypogonadism (IHH) 219
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 207
A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. 203
Classical and non-classical causes of GH deficiency in the paediatric age 203
A novel pathogenic MYH3 mutation in a child with Sheldon–Hall syndrome and vertebral fusions 200
Early-onset central diabetes insipidus is associated with de novo arginine vasopressin-neurophysin II or Wolfram syndrome 1 gene mutations. 197
X-linked agammaglobulinemia and isolated growth hormone deficiency. 196
Clinical Manifestations and Metabolic Outcomes of Seven Adults with Silver-Russell Syndrome 195
Current perspective on the pathogenesis of central diabetes insipidus 194
A case of multiple intestinal atresias, brain anomalies, mental retardation, growth hormone deficiency and clitoris hypertrophy. 188
Management of diabetes insipidus and adipsia in the child. 187
Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease Linked 179
Involvement of hormonal circadian secretion in the growth of HIV-infected children. 178
Cut-off limits of the peak GH response to stimulation tests for the diagnosis of GH deficiency in children and adolescents: Study in patients with organic GHD 178
X-linked hypophosphatemic rickets: an Italian experts' opinion survey 177
Recombinant Human GH Replacement Therapy in Children with Pseudohypoparathyroidism Type Ia: First Study on the Effect on Growth. 176
Idiopathic central diabetes insipidus is associated with abnormal blood supply to the posterior pituitary gland caused by vascular impairment of the inferior hypophyseal artery system. 175
Safety Outcomes during Pediatric GH Therapy: Final Results from the Prospective GeNeSIS Observational Program 175
A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-€“Russell and Beckwith-€“Wiedemann syndromes 173
Pituitary gland imaging and outcome. 173
19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias. 171
Glucokinase mutations in pediatric patients with impaired fasting glucose 170
Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device 170
Central adrenal insufficiency in children and adolescents 170
Contribution of LHX4 mutations to pituitary deficits in a cohort of 417 unrelated patients 169
Posterior pituitary (PP) evaluation in patients with anterior pituitary defect associated with ectopic PP and septo-optic dysplasia. 168
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 168
Accuracy of Glucagon Testing Across Transition in Young Adults with Childhood-Onset Growth Hormone Deficiency 167
Growth Hormone Deficiency in the Transition Age 167
Prevalence and correlates of adherence in children and adolescents treated with growth hormone: A multicenter Italian study 165
Summary of Expert Opinion on the Management of Children With Chronic Kidney Disease and Growth Failure With Human Growth Hormone 165
Role of MRI T2-DRIVE in the assessment of pituitary stalk abnormalities without gadolinium in pituitary diseases 161
Central diabetes insipidus in children and young adults. 160
Relationships between neuroradiological and clinical features in apparently idiopathic hypopituitarism. 158
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 158
Highly conserved non-coding sequences and the 18q critical region for short stature: a common mechanism of disease? 158
Cognitive and White Matter Microstructure Development in Congenital Hypothyroidism and Familial Thyroid Disorders 158
JAG1 loss-of-function variations as a novel predisposing event in the pathogenesis of congenital thyroid defects 157
Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. 157
The growth hormone response to hexarelin in patients with different hypothalamic-pituitary abnormalities. 156
Antipituitary antibodies in patients with pituitary abnormalities and hormonal deficiency. 156
Plasma total adiponectin levels in pediatrics: Reference intervals calculated as a continuous variable of age. 156
Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus. 154
Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. 154
Growth Hormone Registry: A step forward in standard diagnostic practices in Italy. 153
The use of neuroimaging for assessing disorders of pituitary development. 153
Accuracy and limitations of the growth hormone (GH) releasing hormone-arginine retesting in young adults with childhood-onset GH deficiency 153
Endocrine pancreatic dysfunction in HIV-infected children: association with growth alterations. 150
Adult height in children with short stature and idiopathic delayed puberty after different management. 150
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays 150
Midbrain-hindbrain involvement in septo-optic dysplasia. 149
Cognitive Profiles and Brain Volume Are Affected in Patients with Silver-Russell Syndrome 149
Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED) 148
Neuroimaging in Growth hormone deficiency 148
The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults. 147
T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study 147
Correction to: Sleep disturbances in craniopharyngioma: a challenging diagnosis (Journal of Neurology, (2021), 268, 11, (4362-4369), 10.1007/s00415-021-10794-1) 147
Adenosine Blood Level: A Biomarker of White Matter Damage in Very Low Birth Weight Infants 147
Organ- and non-organ-specific auto-antibodies in children with hypopituitarism on growth hormone therapy. 145
Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis. 145
GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections 145
Familial ROBO1 deletion associated with ectopic posterior pituitary, duplication of the pituitary stalk and anterior pituitary hypoplasia 144
Is growth hormone treatment in young children safe for the heart? 143
Validation of the Italian Quality of Life in Short Stature Youth (QoLISSY) questionnaire 143
Comparison of clinical-radiological and molecular findings in hypochondroplasia. 143
Characterization of Two Novel Variants of the Steroidogenic Acute Regulatory Protein Identified in a Girl with Classic Lipoid Congenital Adrenal Hyperplasia 143
Adult panhypopituritarism presenting as idiopathic growth hormone deficiency in childhood: really idiopathic? 142
Hypothalamic-pituitary dwarfism: comparison between MR imaging and CT findings. 142
Pituitary stalk thickening on MRI: when is the best time to re-scan and how long should we continue re-scanning for? 142
Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development 142
Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy. 141
Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. 141
Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study 141
Motor function improvement after intravenous pamidronate in osteoporosis pseudoglioma syndrome. 140
Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children. 140
Growth hormone response to growth hormone-releasing hormone varies with the hypothalamic-pituitary abnormalities. 140
PREDICTIVE ROLE OF THE IMMUNOSTAINING PATTERN OF IMMUNOFLUORESCENCE AND THE TITERS OF ANTIPITUITARY ANTIBODIES AT PRESENTATION FOR THE OCCURRENCE OF AUTOIMMUNE HYPOPITUITARISM IN PATIENTS WITH AUTOIMMUNE POLYENDOCRINE SYNDROMES OVER A FIVE-YEAR FOLLOW-UP.. 140
Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care 140
Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. 139
Bridging the gap: metabolic and endocrine care of patients during transition 139
The accuracy of magnetic resonance imaging and ultrasonography compared with surgical findings in the localization of the undescended testis. 138
Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA. 138
Pitfalls in the Diagnosis of Central Adrenal Insufficiency in Children. 138
Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study. 138
Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate. 138
Autoimmunity, HLA, Gm and Km polymorphisms in Turner's syndrome. 137
Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency. 137
Case 1: An infant with water intoxication. 137
Novel CNS malformations and skeletal anomalies in a patient with Beaulieu-boycott-Innes syndrome 137
Disorders of salt and water balance in children. 136
Catch-up growth and height prognosis in early treated children with congenital hypopituitarism. 136
GERMLINE PROKINETICIN RECEPTOR 2 (PROKR2) VARIANTS ASSOCIATED WITH CENTRAL HYPOGONADISM CAUSE DIFFERENTAL MODULATION OF DISTINCT INTRACELLULAR PATHWAYS. 136
Diagnosis and management of Silver-Russell syndrome: First international consensus statement 136
Poland's syndrome associated with growth hormone deficiency. 135
Evolution of childhood central diabetes insipidus into panhypopituitarism with a large hypothalamic mass: is 'lymphocytic infundibuloneurohypophysitis' in children a different entity? 135
Totale 16.618
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.586
article - articoli 111.767
book - libri 0
conference - conferenze 329
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.490
Totale 233.172
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.632 86 165 183 201 134 147 169 696 114 267 84 386
2022/20232.746 289 167 53 271 401 519 6 236 486 23 260 35
2023/20242.007 75 227 483 198 123 245 131 99 67 58 79 222
2024/20254.947 122 398 125 377 588 520 469 687 217 300 542 602
2025/20269.200 1.052 225 642 667 1.094 804 1.327 440 727 839 552 831
2026/2027670 670 0 0 0 0 0 0 0 0 0 0 0
Totale 35.441